These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 32299765)

  • 41. Role of tumor-associated macrophages in human malignancies: friend or foe?
    Takeya M; Komohara Y
    Pathol Int; 2016 Sep; 66(9):491-505. PubMed ID: 27444136
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Wilms' tumour. Optimal treatment strategies.
    Suryanarayan K; Marina N
    Drugs; 1998 Oct; 56(4):598-605. PubMed ID: 9806106
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anti-tumour strategies aiming to target tumour-associated macrophages.
    Tang X; Mo C; Wang Y; Wei D; Xiao H
    Immunology; 2013 Feb; 138(2):93-104. PubMed ID: 23113570
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic value of proliferating cell nuclear antigen in Wilms' tumour in children.
    Skotnicka-Klonowicz G; Kobos J; Łoś E; Trejster E; Szymik-Kantorowicz S; Daszkiewicz P
    Eur J Surg Oncol; 2002 Feb; 28(1):67-71. PubMed ID: 11869017
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Outcomes of Wilms' tumor in eastern China: 10 years of experience at a single center.
    Yao W; Li K; Xiao X; Gao J; Dong K; Xiao X; Lv Z
    J Invest Surg; 2012 Jun; 25(3):181-5. PubMed ID: 22583015
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Results of Wilms' tumor trial (WT-99) in Shanghai children's medical center].
    Tang JY; Pan C; Xu M; Xue HL; Chen J; Zhao HL; Gu LL; Wang YP
    Zhonghua Er Ke Za Zhi; 2003 Feb; 41(2):131-4. PubMed ID: 14759320
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intracardiac extension of Wilms' tumor. A report of the National Wilms' Tumor Study.
    Nakayama DK; Norkool P; deLorimier AA; O'Neill JA; D'Angio GJ
    Ann Surg; 1986 Dec; 204(6):693-7. PubMed ID: 3024596
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anaplastic histology Wilms' tumors registered to the Japan Wilms' Tumor Study Group are less aggressive than that in the National Wilms' Tumor Study 5.
    Oue T; Koshinaga T; Takimoto T; Okita H; Tanaka Y; Nozaki M; Haruta M; Kaneko Y; Fukuzawa M;
    Pediatr Surg Int; 2016 Sep; 32(9):851-5. PubMed ID: 27473009
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An miR-340-5p-macrophage feedback loop modulates the progression and tumor microenvironment of glioblastoma multiforme.
    Liu Y; Li X; Zhang Y; Wang H; Rong X; Peng J; He L; Peng Y
    Oncogene; 2019 Dec; 38(49):7399-7415. PubMed ID: 31427735
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CD8+ T-cell lymphocytes infiltration predict clinical outcomes in Wilms' tumor.
    Mardanpour K; Rahbar M; Mardanpour S; Mardanpour N; Rezaei M
    Tumour Biol; 2020 Dec; 42(12):1010428320975976. PubMed ID: 33283684
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Wilms' tumour in New Zealand 1960-1986.
    Delahunt B; Bethwaite PB; Nacey JN; Lewis ME; Fraser J
    Br J Urol; 1992 Dec; 70(6):663-8. PubMed ID: 1336698
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tumour-associated microglia/macrophages predict poor prognosis in high-grade gliomas and correlate with an aggressive tumour subtype.
    Sørensen MD; Dahlrot RH; Boldt HB; Hansen S; Kristensen BW
    Neuropathol Appl Neurobiol; 2018 Feb; 44(2):185-206. PubMed ID: 28767130
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression of tumor-associated macrophage in progression of human glioma.
    Ding P; Wang W; Wang J; Yang Z; Xue L
    Cell Biochem Biophys; 2014 Dec; 70(3):1625-31. PubMed ID: 25182001
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Epidemiology, clinical features and treatment outcome of Wilms' tumor in Taiwan: a report from Taiwan Pediatric Oncology Group.
    Hung IJ; Chang WH; Yang CP; Jaing TH; Liang DC; Lin KH; Lin DT; Hsiao CC; Hsieh YL; Chen JS; Chang TT; Peng CT; Shu SG; Lin MT; Chen BW; Lin KS;
    J Formos Med Assoc; 2004 Feb; 103(2):104-11. PubMed ID: 15083240
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment outcomes in patients less than 2 years of age with small, stage I, favorable-histology Wilms' tumors: a report from the National Wilms' Tumor Study.
    Green DM; Breslow NE; Beckwith JB; Takashima J; Kelalis P; D'Angio GJ
    J Clin Oncol; 1993 Jan; 11(1):91-5. PubMed ID: 8380295
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Infiltrates of M2-Like Tumour-Associated Macrophages Are Adverse Prognostic Factor in Patients with Human Papillomavirus-Negative but Not in Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma.
    Snietura M; Brewczynski A; Kopec A; Rutkowski T
    Pathobiology; 2020; 87(2):75-86. PubMed ID: 32036360
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Wilms' tumor--lessons and outcomes--a 25-year single center UK experience.
    Fawkner-Corbett DW; Howell L; Pizer BL; Dominici C; McDowell HP; Losty PD
    Pediatr Hematol Oncol; 2014 Aug; 31(5):400-8. PubMed ID: 24933082
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Wilms' tumor: long-term results from a single institution.
    Zaghloul MS; Hussein MH; el Koutbey M
    J Surg Oncol; 1994 May; 56(1):25-31. PubMed ID: 8176938
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MANAGEMENT AND OUTCOME OF PATIENTS WITH WILMS' TUMOUR (NEPHROBLASTOMA) AT THE MOI TEACHING AND REFERRAL HOSPITAL, ELDORET, KENYA.
    Tenge CN; Were PA; Aluoch LH; Wekesa JW; Patel K; Kuremu RT
    East Afr Med J; 2012 Apr; 89(4):121-7. PubMed ID: 26856036
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Meta-Analysis of the Prognostic and Clinical Value of Tumor-Associated Macrophages in Hepatocellular Carcinoma.
    Zhang J; Chang L; Zhang X; Zhou Z; Gao Y
    J Invest Surg; 2021 Mar; 34(3):297-306. PubMed ID: 31412745
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.